|
Full analysis from AVENANCE: A real-world study of avelumab first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC). |
|
|
Honoraria - Astellas Pharma; BMS; IPSEN; Janssen-Cilag; Merck KGaA; MSD; Novartis; Pfizer; Seagen |
Consulting or Advisory Role - Amgen; AstraZeneca; BMS; Eisai; ipsen; Janssen-Cilag; Merck KGaA; MSD Oncology; Pfizer |
Travel, Accommodations, Expenses - Astellas Pharma; BMS; IPSEN; Janssen-Cilag; MSD; Pfizer |
|
|
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Immunomedics; Janssen; Janssen (Inst); Loxo/Lilly; MSD Oncology; MSD Oncology (Inst); Pfizer/EMD Serono; Roche; Seagen; Taiho Pharmaceutical |
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Basilea (Inst); BMS (Inst); Exelixis (Inst); Gilead Sciences (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Nektar (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst) |
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen Oncology; MSD Oncology; Roche; Seagen |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Astellas Pharma; Ipsen; Janssen; Sanofi |
Research Funding - Bristol-Myers Squibb (Inst); Ipsen (Inst); Pfizer (Inst) |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; Merck KGaA; Pfizer |
Research Funding - Ipsen (Inst); Merck KGaA (Inst); Pfizer (Inst) |
Travel, Accommodations, Expenses - Ipsen; Merck Sharp and Dohme LLC, a subsidiary of Merck and Co., Inc, Rahway, NJ USA; Pfizer |
|
|
Honoraria - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; Ipsen; Janssen-Cilag; MSD Oncology; PFIZER; Roche/Genentech; Sanofi/Aventis |
Travel, Accommodations, Expenses - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; IPSEN; Janssen-Cilag; MSD Oncology; Pfizer; Roche/Genentech; Sanofi/Aventis |
|
Christine Abraham Jaillon |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck KGaA; Merck Sharp and Dohme LLC, a subsidiary of Merck and Co., Inc, Rahway, NJ USA; Pfizer; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Merck Sharp and Dohme LLC, a subsidiary of Merck and Co., Inc, Rahway, NJ USA; Pfizer |
Travel, Accommodations, Expenses - Merck KGaA; Pfizer; Sanofi |
|
|
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; Lilly; Pfizer; Seagen |
|
|
Consulting or Advisory Role - Merck KGaA |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Merck; Pfizer |
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; Merck; Merck KGaA; Pfizer |
Research Funding - Merck (Inst) |
Travel, Accommodations, Expenses - Merck; Pfizer |
|
|
|
Research Funding - Pfizer (Inst) |
|
|
|
|
|
|
|
|
No Relationships to Disclose |